Paper Details
- Home
- Paper Details
The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Author: FaghihF, GreenbergC S, LeslieJ B, SladenR N, SlaughterT F
Original Abstract of the Article :
Despite the efficacy of antifibrinolytic drugs in reducing bleeding after cardiac surgery, concerns remain regarding their potential to promote thrombosis. We examined the effect of the antifibrinolytic drug, epsilon-aminocaproic acid (EACA) on fibrinolysis and thrombin generation during cardiac sur...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1097/00000539-199712000-00008
データ提供:米国国立医学図書館(NLM)
Balancing Bleeding and Thrombosis: The Role of Epsilon-Aminocaproic Acid
The human body is a delicate balance of forces, and maintaining equilibrium is crucial for optimal health. This study explores the role of epsilon-aminocaproic acid (EACA), an antifibrinolytic drug, in cardiac surgery. The researchers aimed to investigate the effect of EACA on fibrinolysis (the breakdown of blood clots) and thrombin generation (the formation of blood clots) during cardiac surgery. They conducted a randomized controlled trial to compare the effects of EACA with saline in a group of patients undergoing coronary artery bypass graft surgery. The results showed that EACA significantly decreased fibrinolytic activity, leading to reduced bleeding. However, it did not affect thrombin generation. This raises concerns that EACA might potentially increase the risk of thrombosis, a condition where blood clots form in the blood vessels.A Balancing Act: Managing Bleeding and Thrombosis
The findings of this study emphasize the complex nature of managing bleeding and thrombosis in surgical settings. While EACA can effectively reduce bleeding, its potential to promote thrombosis needs careful consideration. Further research is necessary to explore strategies for minimizing these risks and optimizing patient outcomes.Navigating the Complexities of Blood Coagulation
The study underscores the delicate balance between bleeding and thrombosis. Understanding the intricate mechanisms of blood coagulation is vital for making informed decisions about medication and surgical procedures. This knowledge can help medical professionals minimize risks and optimize patient care.Dr.Camel's Conclusion
EACA effectively reduces bleeding after cardiac surgery but may potentially increase the risk of thrombosis. This research highlights the need for a nuanced approach to managing blood coagulation during surgery, balancing the benefits of reducing bleeding with the risk of promoting blood clots.Date :
- Date Completed 1997-12-19
- Date Revised 2019-07-04
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.